Paper
17 May 2018 Combined label-free/fluorescence platform based on Bloch surface waves biochips for cancer biomarker detection
Author Affiliations +
Abstract
A biosensor platform based on Bloch Surface Waves and operating in angular interrogation mode is applied to the detection of a clinical biomarker (HER2-neu/ERBB2) related to breast cancer initiation/progression. Preparing regions for specific recognition of different proteins as well as a reference on the biochip enables to correct the signal for nonspecific effects. Additionally, label-free analysis and surface wave enhanced fluorescence detection can be applied and compared directly on the platform. Cell lysates with high and low expression levels of ERBB2 are analyzed. Comparing the signals of such ERBB2 positive and negative samples estimates the limit of detection at 1.7 ng/mL. This is well below the threshold of 15 ng/mL set by the FDA for clinically useful ERBB2 detection in human serum, demonstrating that 1DPC-based biochips are attractive candidates for breast cancer detection/monitoring.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Norbert Danz, Alberto Sinibaldi, Matteo Allegretti, Elisabetta Sepe, Peter Munzert, Patrizio Giacomini, and Francesco Michelotti "Combined label-free/fluorescence platform based on Bloch surface waves biochips for cancer biomarker detection", Proc. SPIE 10685, Biophotonics: Photonic Solutions for Better Health Care VI, 106850X (17 May 2018); https://doi.org/10.1117/12.2306424
Lens.org Logo
CITATIONS
Cited by 1 scholarly publication.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Luminescence

Biological research

Breast cancer

Cancer

Sensors

Biosensors

Proteins

Back to Top